Our activities are diversified across our business segments and markets and are aligned with our purpose to make high-quality medicines accessible to the people who need them.
Offer a broad product portfolio
We offer a broad and differentiated portfolio of more than 670 products. It includes high-quality generic and branded generic medicines and a growing number of in‑licensed and specialty products.
Markets across geographies
We distribute our products in our markets through experienced sales and marketing teams. In the MENA region, around 2,000 representatives and support market our brands to doctors and pharmacists, while our sales teams in the US and Europe sell to a broad range of customers, including the leading wholesalers, pharmacy chains, governments and hospital purchasing organisations.
Develop and innovate
We are building a pipeline of products to meet the evolving needs of patients and healthcare professionals through investments in internal R&D, partnerships and strategic acquisitions.
Manufacture and maintain quality
Our extensive and high-quality manufacturing capabilities are at the heart of what we do. We have 32 plants across the Group that supply our global markets with a broad range of injectable and non-injectable products, including 13 US FDA-inspected plants and 12 EMA-inspected plants.
We provide patients across our markets with high-quality and affordable medicines.
By focusing on the engagement and development of our people, we provide long and rewarding careers for our talented and diverse workforce.
We have a long history of creating value for our shareholders.
- Established a target to reduce our Scope 1 and 2 greenhouse gas emissions by 25% by 2030, using a 2020 baseline year
We act responsibly, advancing health and wellbeing, empowering our people, protecting the environment and building trust through quality in everything we do.